Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Circio Holding ASA

Market Cap 1.81B 186M 162M 150M 141M 263M 17.55B 265M 1.78B 691M 8.65B 699M 684M 29.97B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 1.81B 186M 162M 150M 141M 263M 17.57B 265M 1.78B 692M 8.66B 700M 685M 30.01B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
69.39%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day-2.63%
1 week-7.85%
Current month-17.78%
1 month-33.45%
3 months+39.62%
6 months+499.68%
Current year+535.74%
1 week 6.94
Extreme 6.94
8.29
1 month 6.94
Extreme 6.94
10.82
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
20.4
5 years 0.48
Extreme 0.48
274.5
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
30/11/21Fiscal year

Chief Executive Officer

120,000 0.1386%
19/05/21Buy

Director

21,299 0.0246%
03/12/20Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-2.63%-7.85%+1,012.78%-63.56% 190M
-2.23%-0.03%+61.34%+109.10% 56.24B
+4.60%+5.85%+54.47%+43.04% 43.76B
-1.44%+1.51%-12.94%-17.33% 23.32B
-2.69%-0.95%-3.68%+374.02% 21.34B
+3.22%+3.77%+19.92%-35.05% 15.75B
-0.67%+1.18%+12.91%-39.22% 15.6B
-1.01%-2.97%+27.42%+174.08% 13.18B
+3.07%+3.59%+25.54% - 12.01B
+4.95%+7.51%+123.21%+249.05% 11.87B
Average +0.52%+2.85%+132.10%+88.24% 21.33B
Weighted average by Cap. +0.50%+3.53%+38.88%+97.75%

Financials

2024 2025
Net sales - -
Net income 57.52M 5.92M 5.16M 4.75M 4.47M 8.37M 558M 8.43M 56.57M 21.97M 275M 22.22M 21.74M 953M -45.91M -4.72M -4.12M -3.79M -3.57M -6.68M -445M -6.72M -45.15M -17.53M -219M -17.73M -17.35M -761M
Net Debt -972K -100K -87.16K -80.34K -75.57K -141K -9.43M -142K -956K -371K -4.65M -375K -367K -16.1M 2.24M 231K 201K 186K 175K 327K 21.77M 329K 2.21M 857K 10.73M 867K 849K 37.19M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
19/06/26 7.400 kr -2.63% 8,340,763
17/06/26 7.600 kr +3.40% 9,946,023
16/06/26 7.350 kr -9.59% 8,248,773
15/06/26 8.130 kr -0.37% 2,288,009
12/06/26 8.160 kr +9.09% 7,624,359

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!